EMJENTA 5/25 mg contains Empagliflozin 5 mg + Linagliptin 25 mg. It is a combination oral antidiabetic medicine used to improve blood glucose control in adults with type 2 diabetes mellitus. It works by increasing glucose removal through urine and improving insulin regulation.
Uses:
Management of type 2 diabetes mellitus
Helps control blood sugar levels along with diet and exercise
Used when single diabetes medicines are not sufficient to achieve blood glucose targets
May help reduce cardiovascular and kidney-related risks in suitable patients with diabetes (as prescribed)
Dose:
Adults: Usually 1 tablet once daily, or as directed by a physician
Can be taken with or without food
Maintain adequate fluid intake unless restricted by a doctor
Dose may be adjusted based on blood glucose control and kidney function
Do not stop or change the dose without medical advice